29Apr 21
Spirit Pharmaceuticals Announces Exclusive ANDA OTC Partnership With Unique Pharmaceuticals Ltd./THINQ Pharmaceuticals, Singapore
Partnership includes ANDA OTC products including Cetirizine, Fexofenadine and Loratadine and other significant OTC products coming in the near future. PRESS RELEASE APR 5, 2021 13:00 EDT HAUPPAUGE, N.Y., April 5,…
22Aug 18
Spirit Pharmaceuticals Announces Major Launch of New Private Brand Dosage Forms
Ronkonkoma, NY, August 22, 2018 – Spirit Pharmaceuticals LLC., a global, leading supplier of Over the Counter (OTC) Pharmaceuticals, announces a significant portfolio expansion to their current line, which includes…
05Jun 18
Spirit Pharmaceuticals Names New Executive Senior Director of QA/RA and Strategic Planning
Ronkonkoma, NY, June 5, 2018 – Spirit Pharmaceuticals LLC., a global, leading supplier of Over the Counter (OTC) Pharmaceuticals, announces the appointment Arati Deshpande as Senior Director of QA/RA and…